Aspire Private Capital, LLC Eli Lilly & CO Transaction History

Aspire Private Capital, LLC

$416 Million
Q3 2024

A detailed history of Aspire Private Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Aspire Private Capital, LLC holds 1,748 shares of LLY stock, worth $1.39 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

1,748

Previous 1,732 0.92%

Holding current value

$1.39 Million

Previous $1.57 Million 1.28%

% of portfolio

0.37%

Previous 0.41%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$772.14 - $960.02 $12,354 - $15,360	16 Added 0.92%	1,748 $1.55 Million
Q2 2024 Jul 15, 2024	SELL	$724.87 - $909.04 $13,047 - $16,362	-18 Reduced 1.03%	1,732 $1.57 Million
Q1 2024 Apr 18, 2024	BUY	$592.2 - $792.28 $290,178 - $388,217	490 Added 38.89%	1,750 $1.36 Million
Q4 2023 Feb 01, 2024	BUY	$525.19 - $619.13 $347,150 - $409,244	661 Added 110.35%	1,260 $734,000
Q2 2022 Aug 01, 2022	SELL	$278.73 - $327.27 $836 - $981	-3 Reduced 0.5%	599 $194,000
Q1 2022 May 10, 2022	SELL	$234.69 - $291.66 $3,050 - $3,791	-13 Reduced 2.11%	602 $172,000
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $2,923 - $3,627	13 Added 2.16%	615 $170,000
Q2 2021 Aug 09, 2021	SELL	$180.55 - $233.54 $23,652 - $30,593	-131 Reduced 17.87%	602 $138,000
Q1 2021 May 26, 2021	BUY	$164.32 - $212.72 $20,211 - $26,164	123 Added 20.16%	733 $137,000
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $130 - $172	1 Added 0.16%	610 $103,000
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $49,861 - $57,673	341 Added 127.24%	609 $90,000
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $35,196 - $42,358	258 Added 2580.0%	268 $44,000
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $54,524 - $67,486	-458 Reduced 97.86%	10 $1,000
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $2,990 - $3,252	-28 Reduced 5.65%	468 $52,000
Q2 2019 Aug 13, 2019	BUY	$110.79 - $129.32 $5,539 - $6,466	50 Added 11.21%	496 $55,000
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $33,393 - $39,306	-300 Reduced 40.21%	446 $58,000
Q4 2018 Feb 25, 2019	BUY	$105.9 - $118.64 $71,058 - $79,607	671 Added 894.67%	746 $86,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $7,942 - $8,898	75 New	75 $86,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspire Private Capital, LLC with notifications on news.

Account

Aspire Private Capital, LLC Eli Lilly & CO Transaction History